1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Cancer Market Trends
  5. > Tarceva Forecast

Tarceva Forecast

  • May 2014
  • -
  • BCC Research
  • -
  • 36 pages

The BCC Research Tarceva Forecast is a quantitative forecast model in an easily accessible Microsoft Excel spreadsheet, segmented by specific parameters.

The introductory sample of the Tarceva Forecast Model was already sent in the update earlier today. I have attached it again for your reference.

The model features:

- Market demand forecasts for Tarceva annually for the years 2010 to 2030 by volume (number of patients) and value (in U.S. dollars)
- Segmentation of volume and value for the following regions: U.S., Japan, Europe, Latin America, China, Asia, Middle East
- Patient volumes, with forecasts by causal factors including population by age range, smoker data, and prevalence

Click here to view a data sheet of the Tarceva Forecast Model.

Use the BCC Research Tarceva Forecast to:

- Examine forecasted market demand for Tarceva: competitor assessment; market opportunity assessment
- Identify new business and investment opportunities for products in the lung cancer segment
- Validate other Tarceva market-demand data to which you have access

Tarceva Forecast, a strategic investment product designed to provide critical market data for the pharmaceutical cancer drug Tarceva.
 
Tarveca (Astellas Pharma) is a once-daily, oral, non-chemotherapy prescription drug for the treatment of advanced or metastatic non-small cell lung cancer (NSCLC). Some clinical studies have shown superior patient outcomes from use of Tarceva as a second-line treatment for NSCLC. Starting in 2020, Tarceva begins to lose patent protection in numerous countries.
 
Through Tarceva Forecast, BCC Research provides high-quality intelligence for strategic decision-making regarding future participation in this large and important market. Market players can use Tarceva Forecast to examine forecasted market demand for Tarceva, identify new business and investment opportunities for related products and services, and validate other Tarceva market-demand data.
 
Tarceva Forecast is a quantitative forecast model in an easily accessible Microsoft Excel spreadsheet, segmented by specific parameters, featuring market demand forecasts for Tarceva annually for the years 2010 to 2030 by volume and value. Data transparency and sources are disclosed for patient volumes, with forecasts by causal factors including population by age range, smoker data, and prevalence, as well as for population estimates at the country level and product pricing and currency valuation forecasts. Information is segmented by the following regions:  United States, Japan, Europe, Latin America, China, Asia, Middle East.

Table Of Contents

Tarceva Forecast
Table of Contents

Figure 1 Summary Graphs - Value in U.S.D. and Patient Volumes, by Region, 2010-2030
Table 1 Total Market - Value in U.S.D. and Patient Volumes, by Region, 2010-2030
Table 2 United States Patient Volumes, 2010-2030
Table 3 Europe Patient Volumes, 2010-2030
Table 4 Japan Patient Volumes, 2010-2030
Table 5 China Patient Volumes, 2010-2030
Table 6 Asia Patient Volumes, 2010-2030
Table 7 Africa/Oceania Patient Volumes, 2010-2030
Table 8 Middle East Patient Volumes, 2010-2030
Table 9 Americas Patient Volumes, 2010-2030
Table 10 United States Population by age range, 2010-2030
Table 11 Europe Population by Country, 2010-2030
Table 12 Japan Population, 2010-2030
Table 13 China Population, 2010-2030
Table 14 Asia Population by Country, 2010-2030
Table 15 Africa/Oceania Population by Country, 2010-2030
Table 16 Middle East Population by Country, 2010-2030
Table 17 Americas Population by Country, 2010-2030
Table 18 United States Smoker Data
Table 19 Europe Smoker Data by Country
Table 20 Japan Smoker Data
Table 21 China Smoker Data
Table 22 Asia Smoker Data by Country
Table 23 Africa/Oceania Smoker Data by Country
Table 24 Middle East Smoker Data by Country
Table 25 Americas Smoker Data by Country
Table 26 United States Lung Cancer Data, 1975-2010
Table 27 Global Lung Cancer Data, by Male and Female, by Region
Table 28 United States Pricing, Tarceva Annual Cost
Table 29 Europe Pricing and FX Rate, Tarceva Annual Cost, Currency Conversion Rates 2011-2014
Table 30 Japan Pricing and FX Rate, Tarceva Annual Cost, Currency Conversion Rates 2011-2014
Table 31 China Pricing and FX Rate, Tarceva Annual Cost, Currency Conversion Rates 2011-2014
Table 32 Asia Pricing and FX Rate, Tarceva Annual Cost, Currency Conversion Rates 2011-2014
Table 33 Africa/Oceania Pricing and FX Rate, Tarceva Annual Cost, Currency Conversion Rates 2011-2014
Table 34 Middle East Pricing and FX Rate, Tarceva Annual Cost, Currency Conversion Rates 2011-2014
Table 35 Americas Pricing and FX Rate, Tarceva Annual Cost, Currency Conversion Rates 2011-2014

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Hematological Cancers: Analytical Tool

Hematological Cancers: Analytical Tool

  • $ 11505
  • Industry report
  • August 2016
  • by Bioseeker

Analytical Tools are cancer area specific intelligence and surveillance toolkits within a select number of hot, emerging cancer therapy areas. They are designed to empower biotech/pharma professionals ...

Frontier Pharma: Glioblastoma Multiforme - Cancer Immunotherapies Dominate First-in-Class Product Innovation

Frontier Pharma: Glioblastoma Multiforme - Cancer Immunotherapies Dominate First-in-Class Product Innovation

  • $ 6995
  • Industry report
  • September 2016
  • by GBI Research

Frontier Pharma: Glioblastoma Multiforme - Cancer Immunotherapies Dominate First-in-Class Product Innovation Summary Glioblastoma multiforme (GBM) is a grade IV tumor that arises from astrocytes. It is ...

Drugs and Diagnostics for Hematological Disorders: Global Markets

Drugs and Diagnostics for Hematological Disorders: Global Markets

  • $ 6650
  • Industry report
  • September 2016
  • by BCC Research

Use this report to: - Receive detailed information regarding screening, testing and treatment options for hematological disorders and blood cancer. - Learn about the types of diagnostic and treatment ...

Lung Cancer: Analytical Tool

August 2016 $ 8096

Ovarian Cancer: Analytical Tool

August 2016 $ 8096

Renal Cancer: Analytical Tool

August 2016 $ 8096

Bladder Cancer: Analytical Tool

August 2016 $ 8096

Download Unlimited Documents from Trusted Public Sources

Breast Cancer Statistics in Africa

  • December 2016
    14 pages
  • Breast Cancer  

  • Africa  

View report >

Therapy and Hormone Market in South Korea

  • December 2016
    4 pages
  • Therapy  

    Hormone  

    Cancer  

  • South Korea  

View report >

Cancer Statistics in the UK

  • December 2016
    20 pages
  • Cancer  

  • United Kingdom  

    Europe  

View report >

ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.